• Tidak ada hasil yang ditemukan

IGF 1 LR3 Long R3IGF 1 Longer Life

N/A
N/A
Protected

Academic year: 2017

Membagikan "IGF 1 LR3 Long R3IGF 1 Longer Life"

Copied!
1
0
0

Teks penuh

(1)

Title:

IGF-1 LR3 ˘ Long R3IGF-1 ˘ Longer Life! Word Count:

410 Summary:

IGF-1, also known as somatomedin C, is one of the members of the peptide family, which has structure & size similar to insulin and is released into the liver or in peripheral tissues in response to the growth hormone to make new muscles. It is responsible for the anabolic activities of GH, and builds new muscle by promoting water retention and protein synthesis. It doesn´t only make muscle fibers larger, but also increase them in number.

Keywords: IGF-1 LR3

Article Body:

IGF-1, also known as somatomedin C, is one of the members of the peptide family, which has structure & size similar to insulin and is released into the liver or in peripheral tissues in response to the growth hormone to make new muscles. It is responsible for the anabolic activities of GH, and builds new muscle by promoting water retention and protein synthesis. It doesn´t only make muscle fibers larger, but also increase them in number.

IGF-1 has powerful effect on fat metabolism and helps the body to burn fat quickly. IGF-1 also helps in stimulating and enhancing the bone density and muscle movements. It has anti-aging chemicals in it, and it is considered as a central regulator for increasing lifespan. It helps to increase the growth and strength of muscles. Thus, IGF-1 decreases the recovery period after injury, and alleviates pain, swelling, stiffness associated with arthritis. IGF-1 also helps to improve mental functions such as reflexes and learning ability. It is indeed a neuroprotector as well as a neuropromoter, which helps the brain functions to work properly such as memory, reflexes and learning abilities. It also helps to decrease cholesterol, boost energy levels, enhance sexual well-being and performance, and reduce the risks of heart attacks and strokes.

However, IGF-1 has very short life. Thus, Long R3IGF-1 or IGF-1 LR3, which has longer life, is commonly used. IGF-1 LR3 remains active for hours, and saves the users from the headache of using IGF-1 frequently. IGF-1 LR3 is available in lyophilized powder form or already reconstituted form. IGF-1 LR3 is manufactured by Guangxi Tanghan Zinc & Indium Co., Ltd. IGF-1 LR3 is very popular among muscle builders, but it is not recommended for inexperienced bodybuilders. IGF-1 LR3 doses range from 20mcg up to 120mcg. Often a dose of 80mcg a day for 4 weeks is prescribed. The initial starting dosage is 20-40 mcg. The drug is approved by FDA for use under doctor´s prescription.

However, it´s important to take anabolic steroid for a long period of time, before starting IGF-1 LR3. It is also important to evaluate the hypoglycaemic effects that it produces. Starting IGF-1 LR3 without any prior use of anabolic steroids, can cause several side effect, such as - cancer, accelerated growth of tumors and enlargement of intestinal organs. IGF-1 LR3 can also cause some adverse side effects, such as severe headache, nausea, and possible hypoglycaemia. So, IGF-1 LR3 is not recommended for the people with a history of cancer.

This is a demo version of txt2pdf v.10.1

Referensi

Dokumen terkait

Peraturan Menteri Negara Pemberdayaan Perempuan dan Perlindungan Anak (KPP dan PA RI) Nomor 02 Tahun 2009 tentang kebijakan Kabupaten atau Kota Layak Anak. Peraturan Menteri

Sehubungan dengan hasil evaluasi masing-masing pekerjaan dan memperhatikan ketentuan dalam Peraturan Presiden Nomor : 54 Tahun 2010 tentang Pengadaan Barang/Jasa Pemerintah

Mendahara Kabupaten Tanjung Jabung Timur Tahun Anggaran 2014, untuk Paket Pekerjaan tersebut diatas telah dilaksanakan Pembukaan Penawaran pada Tanggal 11 Juli 2014, dimana

Tujuan perbaikan pembelajaran dalam penelitian ini adalah untuk meningkatkan hasil belajar siswa kelas IV SDK Uwemea Parigi pada pembelajaran PKn dengan

Geragai Kabupat en Tanj ung Jabung Timur Tahun Anggaran 2014, unt uk Paket Pekerj aan t ersebut diat as t el ah dil aksanakan Pembukaan Penawaran pada Tanggal 18 Jul i 2014,

Hasil Uji Statistik F pada Tabel 4.9 diperoleh nilai signifikansi sebesar 0,000 lebih kecil dari 0,05, artinya secara simultan, profitabilitas dan kapitalisasi pasar

Policy makers need to recognise the major processes transforming the world of work (technology, climate change, changing character of production and employment,

Apabila di kemudian hari ternyata terbukti pernyataan di atas tidak benar atau tidak sesuai dengan kondisi senyatanya, maka izin yang telah diberikan bersedia untuk dicabut tanpa